Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

250
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
250
Lung Capacity01:47

Lung Capacity

48.2K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
48.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Banality of Cancer: Entropy As a Third Pillar of Lung Nodule Risk Assessment.

AJR. American journal of roentgenology·2026
Same author

Leaders: know your colleagues.

Current problems in diagnostic radiology·2026
Same author

Tobacco Use, Knowledge of Harms, and Treatment Support Among Patients With Non-Tobacco-Related Cancers: A Multi-Center Survey Study.

Cancer medicine·2026
Same author

Factors Influencing Dictation Errors in Radiology Resident Reports: A Retrospective, Cross-sectional Analysis at a Single Institution.

Academic radiology·2026
Same author

Adverse COVID-19 experiences and physical and psychological outcomes in patients with lung cancer.

Palliative & supportive care·2026
Same author

The VERITAS Trial and the Future of Transthoracic Biopsy: A Call to Action for Radiologists.

AJR. American journal of roentgenology·2025

Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

990

Understanding the Dramatic Shift in Reported Lung Cancer Screening Rates: Methodologic Changes in the American Lung

Peter R Gunderman1, Zach Jump2, Nasser Hanna1

  • 1Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 550 N University Blvd, Rm 0663, Indianapolis, IN 46202.

AJR. American Journal of Roentgenology
|April 2, 2025
PubMed
Summary

Lung cancer screening rates appear to surge due to a data source change, not improved access. Understanding this methodological shift is crucial for accurate lung cancer statistics interpretation.

More Related Videos

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.2K
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.6K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

990
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.2K
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.6K

Area of Science:

  • Pulmonary Medicine
  • Public Health Surveillance
  • Health Services Research

Background:

  • Lung cancer screening rates are a key indicator of early detection efforts.
  • Accurate screening statistics are vital for policy development and resource allocation.

Purpose of the Study:

  • To examine the reported increase in national lung cancer screening rates.
  • To analyze the impact of a methodological data source change on these statistics.
  • To discuss implications for research and policy regarding lung cancer screening.

Main Methods:

  • Comparison of lung cancer screening data from the American College of Radiology (ACR) lung cancer screening registry.
  • Analysis of lung cancer screening data from the Behavioral Risk Factor Surveillance System (BRFSS).
  • Evaluation of the transition between these two data collection methods.

Main Results:

  • A significant reported increase in lung cancer screening rates from 4.5% (2023) to 16.0% (2024) was observed.
  • This increase is attributed to a methodological change, specifically switching data sources from the ACR registry to the BRFSS.
  • The transition in methodology, not necessarily an increase in actual screening, explains the statistical rise.

Conclusions:

  • The dramatic rise in reported lung cancer screening rates is an artifact of a methodological data source change.
  • Interpreting screening statistics requires careful consideration of the underlying data collection methods.
  • Future research and policy decisions must account for this methodological transition to avoid misinterpretations of lung cancer screening trends.